Systematic Evidence Database: PubMed-Indexed Studies of Medicinal Mushroom Polysaccharides, Plant-Derived Anxiolytics, and Lipid-Modulating Compounds in Cardiovascular, Neurological, and Immunological Applications

A comprehensive evidence database cataloging PubMed-indexed studies on bioactive compounds with documented effects in cardiovascular, neurological, and immunological health applications. Each entry was individually verified against NCBI PubMed records. Compounds covered: lentinan (Lentinus edodes), polysaccharide-K (Coriolus versicolor), astaxanthin (Haematococcus pluvialis), Auricularia auricula-judae polysaccharides, Pleurotus ostreatus lovastatin, policosanol, monacolin K, Passiflora incarnata flavonoids (vitexin, chrysin, apigenin), and Hericium erinaceus neurotrophic compounds. Structure: Each entry includes PubMed ID, study title, first author, publication year, journal, study type (meta-analysis, systematic review, RCT, clinical trial, in vivo, in vitro, or mechanism study), ingredient with Latin binomial, ICD-10 condition mapping, primary mechanism or pathway, quantitative outcome summary, sample size where applicable, evidence quality grading, and DOI. Current version: 292 unique studies across 294 ingredient–condition entries, including 21 meta-analyses, 5 systematic reviews, 24 randomized controlled trials, 35 clinical trials, 66 in vivo studies, 18 in vitro studies, and 10 mechanism studies. Compiled by BioLabs.lt to catalog the evidence base for bioactive compounds used in formulations by Zenius Labs™. Companion to: Multi-Pathway Cholesterol Management with Policosanol, Monacolin K, Auricularia auricula-judae, and Pleurotus ostreatus (DOI: 10.5281/zenodo.19400298). Available in CSV and JSON formats. Licensed under CC BY 4.0.